Overview
- Telangana IT and Industries Minister D. Sridhar Babu formally inaugurated the TheraNyM facility at Borpatla village in Sangareddy, a project built at an outlay of ₹1,200 crore and presented as operational by company and state officials.
- TheraNyM says the site will produce medicines used to treat cancer and other life‑threatening illnesses and that products will be exported to multiple international markets, including the United States.
- The company and the state say the project could create more than 1,500 local jobs and strengthen Telangana’s push to grow its life‑sciences manufacturing base under the 'Made in Telangana' label.
- The plant builds on a previously disclosed master services agreement between TheraNyM and Merck Sharp & Dohme for contract manufacturing, and company statements report planned further investment for large mammalian bioreactors and high‑volume vial filling tied to MSD orders.
- Analysts note the inauguration translates planned capacity into a physical site but that the larger Unit 2 expansion and the roughly ₹1,000 crore of additional investments are reported company plans that will need separate commissioning and third‑party verification.